Cost–utility and cost-effectiveness of physical exercise during adjuvant chemotherapy

from The European Journal of Health Economics at http://bit.ly/2tkagrK on June 19, 2018 at 02:16PM Abstract Introduction A home-based, low-intensity physical activity program (Onco-Move) and a supervised, moderate-to-high intensity, combined resistance and aerobic exercise program (OnTrack) have proven to be effective in maintaining physical fitness and reducing fatigue among breast cancer patients undergoing adjuvant chemotherapy. […]

The Application of Triple Aim Framework In The Context Of Primary Healthcare: A Systematic Literature Review

from Health Policy at http://bit.ly/2I25N2e on June 19, 2018 at 12:15PM Publication date: Available online 18 June 2018 Source:Health Policy Author(s): M. Obucina, N. Harris, J.A. Fitzgerald, A. Chai, K. Radford, A. Ross, L. Carr, N. Vecchio The Triple Aim framework is an increasingly popular tool for designing and assessing quality improvements in the health […]

Little to lose and no other options: Ethical issues in efforts to facilitate expanded access to investigational drugs

from Health Policy at http://bit.ly/2K3lFq4 on June 19, 2018 at 12:15PM Publication date: Available online 18 June 2018 Source:Health Policy Author(s): Eline M. Bunnik, Nikkie Aarts, Suzanne van de Vathorst Today, public and private bodies around the world are trying to facilitate and increase expanded access to unapproved, investigational drugs for patients with unmet medical […]

Cost-Effectiveness of Obinutuzumab in Combination with Bendamustine Followed by Obinutuzumab Maintenance versus Bendamustine Alone in Treatment of Patients with Rituximab-Refractory Follicular Lymphoma in Norway

from Applied Health Economics and Health Policy at http://bit.ly/2JYqVbh on June 19, 2018 at 10:09AM Abstract Aims To evaluate the cost-effectiveness of obinutuzumab in combination with bendamustine followed by obinituzumab maintenance (Obin-Benda) compared to bendamustine alone (Benda) in patients with refractory follicular lymphoma (FL) in a Norwegian setting. Methods A three-state area-under-the-curve (AUC) model was […]

Health State Values Derived from People with Multiple Sclerosis for a Condition-Specific Preference-Based Measure: Multiple Sclerosis Impact Scale–Eight Dimensions–Patient Version (MSIS-8D-P)

from Value in Health at http://bit.ly/2K6v9Ba on June 19, 2018 at 08:36AM Publication date: Available online 19 June 2018 Source:Value in Health Author(s): Elizabeth Goodwin, Colin Green, Annie Hawton In economic evaluation, health outcomes are commonly quantified using quality-adjusted life-years (QALYs) derived from the preferences of a sample of the general population. It can be […]

A prospective observational study to assess clinical decision-making, prognosis, quality of life and satisfaction with care in patients with relapsed/refractory multiple myeloma: the CLARITY study protocol

from Health and Quality of Life Outcomes at http://bit.ly/2K1pBVi on June 19, 2018 at 12:33AM Treatment decision-making in patients with relapsed/refractory multiple myeloma (RRMM) is challenging for a number of reasons including, the heterogeneity of disease at relapse and the number of possible thera…